Is Lenvatinib on for 21 days and off for 7 days?

When Lenvatinib (Lenvatinib) is used to treat certain types of cancer, a 21-day continuous medication cycle is usually adopted, that is, a certain dose of the drug is taken orally every day, used continuously for 21 days, and then stopped for 7 days to form a treatment cycle. This treatment regimen is called the 21/7 regimen, also known as the 21 day continuous dosing cycle.

The medication cycle using the 21/7 regimen has certain scientific basis and clinical practice experience. Its main purpose is to minimize the side effects and toxicity of the drug while ensuring the efficacy of the drug, so as to improve the patient's quality of life and treatment compliance.

During 21 days of continuous treatment, Lenvatinib (Lenvatinib) will continue to inhibit the growth and spread of tumor cells, thereby achieving the purpose of controlling tumors. During the drug withdrawal period, the patient's body has the opportunity to restore certain drug metabolism and immune system functions, reduce the side effects of the drug, and also help reduce the patient's tolerance to the drug.

In the21/7 plan, patients need to strictly follow the doctor's instructions to take medication and maintain a regular medication cycle and dosage. At the same time, doctors will make adjustments based on the patient's specific situation and the efficacy of the drug, such as adjusting the drug dosage or treatment plan based on the patient's tumor response and drug tolerance, in order to achieve the best therapeutic effect.

Although the 21/7 regimen can reduce the side effects of the drug to a certain extent, some adverse reactions may still occur, such as fatigue, loss of appetite, hypertension, hand-foot syndrome, etc. Therefore, during the medication period, patients need to closely observe their physical condition and report it to the doctor in time for timely adjustment and treatment.

In general, the lenvatinib (lenvatinib) treatment plan using the 21/7 plan not only improves the treatment effect, but also takes into account the patient's quality of life and the safety of the drug, bringing certain benefits to the patient.